Andrew Rowland

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Joshua A Welsh, Deborah C. I. Goberdhan, Lorraine O’Driscoll et al. · Journal of Extracellular Vesicles · 2024 · 3.7K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer

Ganessan Kichenadasse, John O. Miners, Arduino A. Mangoni et al. · JAMA Oncology · 2019 · 347 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

IN VITRO CHARACTERIZATION OF LAMOTRIGINE N2-GLUCURONIDATION AND THE LAMOTRIGINE-VALPROIC ACID INTERACTION

Andrew Rowland, David J. Elliot, J. Andrew Williams et al. · Drug Metabolism and Disposition · 2006 · 224 citations

Life Sciences, Biochemistry, Pharmacology +17

The “Albumin Effect” and Drug Glucuronidation: Bovine Serum Albumin and Fatty Acid-Free Human Serum Albumin Enhance the Glucuronidation of UDP-Glucuronosyltransferase (UGT) 1A9 Substrates but Not UGT1A1 and UGT1A6 Activities

Andrew Rowland, Kathleen Knights, Peter I. Mackenzie et al. · Drug Metabolism and Disposition · 2008 · 181 citations

Life Sciences, Biochemistry, Pharmacology +12

Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo Extrapolation

Andrew Rowland, David J. Elliot, Peter I. Mackenzie et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 166 citations

Life Sciences, Biochemistry, Pharmacology +13